| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-06 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.007 |